The answer to the question about whether it’s appropriate to call one of President-elect Trump’s latest cabinet nominees by ...

Whether millions gain access to breakthrough anti-obesity treatments may depend on Kennedy, Mehmet Oz and other key players ...

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

Nominated by Trump to oversee Medicare and Medicaid, the celebrity doctor continues to peddle dubious health products ...

The former and future President will be entering office in January 2025 with a Republican House and Senate, and he has ...

While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...

Biden's enhanced Affordable Care Act subsides lowered costs for millions. Trump could let the subsides expire in 2025.

In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body ...

With over 2,300,000 renters in New York City, it’s a good bet most of them had to pay exorbitant brokers’ fees to land their ...

Stanford University professor of health policy and skeptic of COVID-19 precautions Is Trump's pick to run the National ...

Under Secretary for Health Dr. Shereef Elnahal said Monday the VA needs extra funding to cover the costs of drugs such as ...

Kakistocracy” is trending again. The obscure term, coined as early as the seventeenth century and defined by Merriam-Webster ...